Magenta Therapeutics
Manufacturing · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
100 Technology Sq Fl 5, Cambridge, Massa...Website
www.magentatx.comRevenue
$15.9 MillionIndustry
About Magenta Therapeutics
Magenta Therapeutics Org Chart
Is Magenta Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Click to see if Magenta Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Magenta Therapeutics is spiking on competitors!
Product Launch: Get notified when Magenta Therapeutics launches new products
Funding: Get notified immidiatlly once Magenta Therapeutics has new funding data
Earning: See what the market has to say on Magenta Therapeutics recently announced quarterly report
Magenta Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Magenta Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Magenta Therapeutics
Recommended Actions
Find VP level buyers at Magenta Therapeutics
Find 3 more new buyers
Compare Similar Companies to Magenta Therapeutics
Compare insights from companies similar to Magenta Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Magenta Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Magenta Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Magenta Therapeutics.
Magenta Therapeutics financials insights
Gather financial insights about Magenta Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$48.5M
Series B
$50M
Series C
$52M
Stock Offering
$100M
Stock Offering
$60M
Stock Offering
$86.4M
Magenta Therapeutics Tech Stack
A closer look at the technologies used by Magenta Therapeutics
Most Recent Scoops
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Magenta Therapeutics
Magenta Therapeutics is focused in developing medicines to make cures possible for more patients with blood cancers, genetic diseases and autoimmune diseases.... Read More